Supplemental material
Articles
Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience
Matthias N. Ungerera Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;b Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany
https://orcid.org/0000-0002-8510-9237
https://orcid.org/0000-0002-8510-9237, Ernst Hunda Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;b Department of Neurology, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0002-6158-1190
https://orcid.org/0000-0002-6158-1190, Jan C. Purruckera Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;b Department of Neurology, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0003-2978-4972
https://orcid.org/0000-0003-2978-4972, Laura Hubera Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;c Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0003-2873-026X
https://orcid.org/0000-0003-2873-026X, Christoph Kimmicha Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;c Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0001-9880-4223
https://orcid.org/0000-0001-9880-4223, Fabian aus dem Siepena Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;d Department of Medicine III, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0003-4264-1722
https://orcid.org/0000-0003-4264-1722, Selina Heina Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;d Department of Medicine III, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0003-0139-4200
https://orcid.org/0000-0003-0139-4200, Arnt V. Kristena Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;d Department of Medicine III, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0001-7657-3700
https://orcid.org/0000-0001-7657-3700, Katrin Hinderhofera Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;e Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0003-1493-4608
https://orcid.org/0000-0003-1493-4608, Jennifer Kollmera Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;f Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0002-6254-9192
https://orcid.org/0000-0002-6254-9192, Stefan Schönlanda Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;c Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0002-4853-5579
https://orcid.org/0000-0002-4853-5579, Ute Hegenbarta Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;c Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germanyhttps://orcid.org/0000-0003-1917-6746
https://orcid.org/0000-0003-1917-6746 & Markus Weilera Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany;b Department of Neurology, Heidelberg University Hospital, Heidelberg, GermanyCorrespondence[email protected]
https://orcid.org/0000-0002-8942-7662
https://orcid.org/0000-0002-8942-7662 show all